ETFs MedPacto, Inc.

A235980

KR7235980000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-10-30			5-day change	1st Jan Change
3,050.00 ^KRW	+2.69%		-0.16%	-54.34%

09-20	MedPacto, Inc.(KOSDAQ:A235980) dropped from S&P Global BMI Index	CI
08-13	MedPacto, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

ETFs positioned on MedPacto, Inc.

Name	YTD change	Weight	AuM
STATE STREET SPDR S&P INTERNATIONAL SMALL CAP ETF - USD	+7.49%	0.01%	918 M€
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP ETF - USD	+3.29%	0%	12,001 M€
STATE STREET SPDR PORTFOLIO DEVELOPED WORLD EX-US ETF - USD	+11.12%	0%	41,780 M€
STATE STREET SPDR GLOBAL ALLOCATION ETF - DISTRIBUTING - USD	+5.54%	0%	317 M€
DEFINED DURATION 20 ETF - USD	+10.21%	0%	19 M€
VANGUARD ALL-EQUITY ETF PORTFOLIO - CAD	+13.13%	0%	12,086 M€
DISCIPLINE FUND ETF - USD	-.--%	0%	73 M€
VANGUARD BALANCED ETF PORTFOLIO - CAD	+6.14%	0%	4,204 M€
DEFINED DURATION 5 ETF - USD	+0.72%	0%	18 M€
WARREN STREET GLOBAL EQUITY ETF - USD	+11.65%	0%	62 M€

MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.

Employees

Sector

Biotechnology & Medical Research

More about the company